Novartis India has informed that based on the recommendation of Nomination and Remuneration Committee and pursuant to the provisions of Section 203 of the Companies Act, 2013, the Board of Directors of the Company at its meeting held today May 08, 2024 has approved the appointment of Chandni Maru (ICSI Membership Number- A60291) as the Company Secretary and Key Managerial Personnel of the Company with an immediate effect (from the conclusion of the said Board Meeting held today May 08, 2024). Further, the Board of Directors has also approved appointment of Chandni Maru as the Compliance Officer of the Company as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015, as may be amended from time to time, with an immediate effect. The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, with respect to the appointment of Company Secretary and Compliance Officer are enclosed as an Annexure A.
The above information is a part of company’s filings submitted to BSE.